A Study of a FimH Blocker, EB8018, in Crohn's Disease Patients
Condition: Crohn Disease Intervention: Drug: EB8018 (First-in-class FimH blocker) Sponsor: Enterome Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials